EUVIMEDEUVIMED entdecken
Crossref

Kidney Selective Bcl2 Inhibitor Delivery Improves Fibrosis Treatment

Humayra Afrin iD, Sayantani Chakraborty, Md Nafiujjaman, Md Nurul Huda iD, Taeho Kim iD, Lela Vukovic, Yong-Kyu Lee, Md Nurunnabi iD

ACS Applied Bio Materials · 02.06.2026

DOI: 10.1021/acsabm.6c00062 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, online erschienen am 02.06.2026. Verfasst von Humayra Afrin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, School of Pharmacy, University of Texas at El Paso, El Paso, Texas 79902, United States. Hauptthemen laut MEDLINE: Fibrosis, Proto-Oncogene Proteins c-bcl-2, Kidney, Biocompatible Materials. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibrosisProto-Oncogene Proteins c-bcl-2KidneyBiocompatible MaterialsSulfonamidesKidney DiseasesAniline CompoundsAnimalsMicePolylactic Acid-Polyglycolic Acid CopolymerNanoparticlesHumansMaterials TestingApoptosisParticle Size

Stichwörter der Autor:innen

fibrosiskidneynanoparticlenavitoclaxtargeted therapy

Substanzen

Proto-Oncogene Proteins c-bcl-2Polylactic Acid-Polyglycolic Acid CopolymerBiocompatible MaterialsSulfonamidesAniline Compoundsnavitoclax

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, School of Pharmacy, University of Texas at El Paso, El Paso, Texas 79902, United States.
  • Division of Nephrology and Hypertension, Mayo Clinic Rochester, Minnesota 55904, United States.
  • Department of Chemistry and Biochemistry, College of Sciences, University of Texas at El Paso, El Paso, Texas 79968, United States.
  • Department of Biomedical Engineering, Institute for Quantitative Health Science and Engineering, Michigan State University, East Lansing, Michigan 48824, United States.
  • Department of Chemical and Biological Engineering, Korea National University of Transportation, Chungju 27469, Republic of Korea.

ORCID-Profile: Humayra Afrin, Md Nurul Huda, Taeho Kim, Md Nurunnabi

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Afrin, H., Chakraborty, S., Nafiujjaman, M., Huda, M. N., Kim, T., Vukovic, L., Lee, Y. K., & Nurunnabi, M. (2026). Kidney Selective Bcl2 Inhibitor Delivery Improves Fibrosis Treatment. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.6c00062

Vancouver

Afrin H, Chakraborty S, Nafiujjaman M, Huda MN, Kim T, Vukovic L, et al. Kidney Selective Bcl2 Inhibitor Delivery Improves Fibrosis Treatment. ACS Applied Bio Materials. 2026. doi:10.1021/acsabm.6c00062

BibTeX
@article{Afrin2026,
  author = {Afrin, Humayra and Chakraborty, Sayantani and Nafiujjaman, Md and Huda, Md Nurul and Kim, Taeho and Vukovic, Lela and Lee, Yong-Kyu and Nurunnabi, Md},
  title = {Kidney Selective Bcl2 Inhibitor Delivery Improves Fibrosis Treatment},
  journal = {ACS Applied Bio Materials},
  year = {2026},
  doi = {10.1021/acsabm.6c00062}
}
Kostenlos starten →